Why Aurora (TSX:ACB) Stock Fell 4% on Wednesday

Aurora Cannabis (TSX:ACB)(NYSE:ACB) fell after management declared a “rocky road” ahead, but should investors give up on Aurora stock?

Aurora Cannabis (TSX: ACB)(NYSE:ACB) saw shares drop 4% on Wednesday after an earnings release that missed analyst estimates. However, not all is lost for Aurora stock. Let’s see what’s going on with this cannabis company.

What happened?

Aurora stock announced an earnings loss of $11.9 million for its most recent quarter, stating it would continue with the strategy of focusing on premium products. Rather than chase the lower profit margins that the company has in the past, and where others focus, Aurora stock sees the premium business as “rational,” though investors are “in for a little bit of a more rocky road.”

The company managed to beat earnings estimates, coming in at a loss of $0.06 per share. This is far higher than the loss of $0.21 EPS expected by analysts and the loss of $0.85 per share from the same quarter last year.

However, Aurora stock came below revenue estimates, reaching $60.1 million for the quarter, down from $67.6 million the year before.

So what?

The drop in the share price of Aurora stock wasn’t that much, and it’s clear why. While the short-term “rocky road” predicted by management isn’t great, in the long term, this could be what Aurora stock needs — especially as it recently acquired Growery to start selling recreational cannabis in Dutch coffee shops in a four-year experiment.

Analysts also started to raise their target for the company. Aurora stock received a boost to $10 from one analyst shortly after earnings, providing a potential upside of 11% over the next year.

Now what?

Aurora stock may start to go in a positive direction, with at least some kind of clear focus after so many losses. In fact, it was the first time in quite a while that the company managed to beat out EPS estimates, so that’s definitely positive.

But should you buy? That’s the real question. I would hold off for now. Aurora stock didn’t plummet, sure, but it didn’t soar either. And management doesn’t seem too confident in the immediate future of the company. That being said, management has certainly improved items like cash burn, dropping from $142.8 million last year to $16.55 million this quarter. With $424.3 million in cash and cash equivalents on the books, it’s certainly healthier than it was.

Aurora stock continues to dominate the medical marijuana field, but it still has to prove itself in the recreational sector. While premium is a dream for now, it could be the boost the company needs for future investors.

Shares were down 4% Wednesday morning.

Fool contributor Amy Legate-Wolfe owns shares of Aurora Cannabis. The Motley Fool has no position in any of the stocks mentioned.

More on Cannabis Stocks

Medicinal research is conducted on cannabis.
Cannabis Stocks

Top Canadian Stocks to Buy Right Now With $1,000

Cannara, Source Energy and CareRx just updated investors. See what $1,000 can buy in these Canadian stocks, plus the risks…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Stocks for Beginners

This Cannabis Stock Jumped 12% in a Day: The Math Says Be Careful

Tilray's record revenue came with declining cannabis sales and negative free cash flow, making the investment much more speculative than…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf’s Takeover Bid for Aurora Cannabis: What Investors Need to Know

Curaleaf's takeover bid for Aurora Cannabis offers a premium but brings stock, debt, and deal risks. Here’s what ACB investors…

Read more »

Cannabis business and marijuana industry concept as the shadow of a dollar sign on a group of leaves
Cannabis Stocks

Curaleaf Just Announced a Hostile Takeover Bid for Aurora Cannabis. Here’s What This Means for Investors.

It's appealing directly to the Canadian company's shareholders with a cash-and-stock offer.

Read more »

runner checks her biodata on smartwatch
Cannabis Stocks

Average TFSA and RRSP Balances at Age 45: Are You on Par?

Most 45-year-olds have less than $100,000 combined in their TFSA and RRSP. Here's how TerrAscend could help you close the…

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Risky Stocks That Could Send Your $100,000 Investment to $0

Cannabis stocks look risky because price wars, dilution, and regulation can turn one weak quarter into a long drawdown.

Read more »

Pot stocks are a riskier investment
Cannabis Stocks

My Biggest Investing Regret in 2025 Was Buying This Stock

Canopy Growth is a cautionary reminder to buy businesses, not headlines, especially in hype-driven sectors like cannabis.

Read more »

Yellow caution tape attached to traffic cone
Cannabis Stocks

2 Popular Stocks That Could Wipe Out a $100,000 Nest Egg

Aurora Cannabis (TSX:ACB) is one stock that could wipe out your nest egg.

Read more »